ClosedRegulation
Abbott Laboratories, Inc.; Withdrawal of Approval of a New Drug Application for MERIDIA
Health and Human Services Department, Food and Drug Administration
Closed
NAICS 325412
Source: Federal Register
OverviewIntelligenceProposals
Key Details
- Posted Date
- Response Deadline
- NAICS Code
- 325412
- Source
- Federal Register
- Contract Type
- regulation
Description
The Food and Drug Administration (FDA) is withdrawing approval of a new drug application (NDA) for MERIDIA (sibutramine hydrochloride (HCl)) oral capsules held by Abbott Laboratories, Inc. (Abbott), 100 Abbott Park Rd., Abbott Park, IL 60064. Abbott has voluntarily requested that approval of this application be withdrawn, thereby waiving its opportunity for a hearing.
Key Dates
Posted:→Deadline:
Frequently Asked Questions
Is this regulation still open?+
No — the response deadline for this regulation has passed (December 21, 2010). Browse other active Health and Human Services Department, Food and Drug Administration opportunities on Bureauify.
How do I apply for this regulation?+
Review the full solicitation documents on the source website (SAM.gov or Grants.gov), prepare your proposal per the instructions, and submit before the deadline. Use Bureauify to track the opportunity and get reminders.
Track This Regulation
Get alerts and track updates with Bureauify.
Track in BureauifyView on Federal RegisterIntelligence
- Win probability analysis
- Competitive landscape
- Incumbent analysis
- Price-to-win estimate
- Similar awards history
Data sourced from Federal Register